RAMSEY KEYES: Open Payments
NPI 1174194427 · BEDFORD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,277 in 41 payments from 23 companies in 2025. Trend: 2023 $604 · 2024 $965 · 2025 $1,277
Food & beverage: $1,079Education: $195Speaker / faculty: $2
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 8 | $272 |
| Janssen Biotech, Inc. | 3 | $143 |
| AstraZeneca Pharmaceuticals LP | 2 | $132 |
| Novartis Pharmaceuticals Corporation | 4 | $104 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $93 |
| PFIZER INC. | 3 | $56 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| Myriad Genetic Laboratories, Inc. | 1 | $41 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $35 |
Products named: Enhertu, DARZALEX, Nubeqa, Fabhalta, JEMPERLI, MYRISK, KEYTRUDA, LYNOZYFIC.
Industry payments across TX — which companies pay providers there.
